about
Corticosteroids for the treatment of Kawasaki disease in childrenTherapeutic advances in the treatment of vasculitisImpact of Immunoglobulin Therapy in Pediatric Disease: a Review of Immune Mechanisms.Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europeRisk factors and implications of progressive coronary dilatation in children with Kawasaki diseaseKawasaki disease in children: Epidemiology, clinical symptoms and diagnostics of 231 cases in 10 yearsCardiovascular status after Kawasaki disease in the UK.Corticosteroids for the treatment of Kawasaki disease in children.Uveitis as an important ocular sign to help early diagnosis in Kawasaki disease.Echocardiographic pattern of acquired heart diseases in NigeriaMedication Repurposing in Pediatric Patients: Teaching Old Drugs New TricksKawasaki disease incidence in children and adolescents: an observational study in primary care.Monoclonal antibody therapy for Kawasaki disease: a protocol for systematic reviews and meta-analysis.Identification of candidate diagnostic serum biomarkers for Kawasaki disease using proteomic analysisIL-1 Inhibition May Have an Important Role in Treating Refractory Kawasaki Disease.Kawasaki disease: pathophysiology, clinical manifestations, and management.Intravenous immunoglobulin-related hemolysis in patients treated for Kawasaki disease.Kawasaki disease and coronary artery aneurysms: from childhood to adulthood.Immune Gamma Globulin Therapeutic Indications in Immune Deficiency and Autoimmunity.Identification of Differentially Expressed Genes in Kawasaki Disease Patients as Potential Biomarkers for IVIG Sensitivity by Bioinformatics Analysis.Unexpected coronary arterial calcification and thrombosis late after Kawasaki disease.Kawasaki Disease with Fever and Cervical Lymphadenopathy as the Sole Initial Presentation.The incidence of Kawasaki disease after vaccination within the UK pre-school National Immunisation Programme: an observational THIN database study.Predicting IVIG resistance in UK Kawasaki disease.Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm.Early Desquamating Perineal Erythema in a Febrile Infant: A Characteristic Clinical Feature of Kawasaki Disease.Myocardial Assessment in School-Aged Children with Past Kawasaki Disease.Is aspirin necessary in the acute phase of Kawasaki disease?Clinical Analysis of Kawasaki Disease Shock Syndrome.Treatment Options for Resistant Kawasaki Disease.Usefulness of Age-Stratified N-Terminal Prohormone of Brain Natriuretic Peptide for Diagnosing Kawasaki Disease.Controversies in diagnosis and management of Kawasaki disease.Role of glucocorticoids in Kawasaki disease.Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.Giant coronary artery aneurysms in a 12-week-old infant with incomplete Kawasaki disease.Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD)Giant right coronary artery aneurysm secondary to Kawasaki disease in an infantAuthors' response to ‘Aspirin dose for treatment of Kawasaki disease’
P2860
Q24194653-06AA1604-21E1-4064-9243-0921B77203E6Q26750499-DEACEE3D-8D79-4849-8955-A67542D67B0CQ30252123-005A87EF-A379-4069-A5B9-5F03EBABE1A9Q33419638-6D79796F-6DFA-44AC-A105-7808814D3B21Q33771697-7F6AB100-3BE3-4EAF-983E-B2ED98BFD916Q35802942-D055A88B-4E04-4FE7-AB91-30F6D1A40B24Q36209060-CCA5B0F0-B926-405C-82B9-74F96F893038Q36262749-4F851984-41D9-4CE4-808A-AC56FC392273Q36279892-B3C2CB55-90C5-4D70-8294-55771AC9F0F5Q36419371-750E2429-4844-4E26-96DA-7A83810A7C52Q36652800-BD9818E4-EFCD-43A2-A35E-30F0C6F34E65Q36734312-A31C3864-925E-408D-B82A-CA47696793A9Q36793618-CAA0BB61-89C9-4805-837F-3DD380707CADQ37681879-9C7D2452-6A35-43CF-A554-5B3153C2A545Q37723505-BD5FFEC0-717D-454E-AFAD-7C46F1492B05Q38205391-C5CCA8A9-01A9-4D1C-958E-B4FF084CA18FQ38547199-82D76141-CB03-445B-91B2-26B1E8172400Q38638912-A9FC81BF-F03D-49C6-9CAD-A737F1BF5903Q38842992-C4FE4B67-8FD5-4390-982F-74A8822C3FC7Q38869612-5E2DEEDA-C58B-4843-9A23-822CB3545F56Q39138234-8A58EBB4-7BCD-4847-9730-11C3A26921C8Q40070636-2AFFC545-7EA3-4A04-8023-D59C4F6F2B1CQ40498431-9BB49D3E-87A5-4E37-B53C-D1D908210731Q41491226-D0204E2E-34A1-4A3D-969C-282813FE1B29Q41601611-6CF96219-86E7-4DB1-A547-675C04F457C1Q42344204-0EB6FE23-BCCB-4409-B513-0878B0F95555Q42702650-A46A46B0-3FB7-4620-9AB4-F1CD3A70194BQ47261379-A0ACE8D8-E381-4620-ACA0-90DC350F52AFQ47308947-2A0860AC-F962-4B1D-8C99-CB65FC6F5CFAQ47660588-F0E5EA86-EEBE-47B6-8847-CCA312CCADD3Q47846103-12E3F712-1049-4D9B-9247-5F6FF3120710Q49873428-C8F8A5BB-9368-41E3-9C2D-38162AC80D89Q50144746-EDA6015F-999E-42F1-B9DF-681394F97A4AQ51735974-79606C60-3EB0-4497-A049-42981D842319Q54246635-0CCDEF76-674F-489D-9E29-85927134D0FAQ57316200-2285CCF5-DCBF-4794-B55B-1A948558C5A4Q58543347-D4BA72DE-8977-4BB3-A102-AE72FA63EF4FQ58809663-F10DFDB6-819B-4B9B-B19D-9491D18C57C6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management of Kawasaki disease.
@en
Management of Kawasaki disease.
@nl
type
label
Management of Kawasaki disease.
@en
Management of Kawasaki disease.
@nl
prefLabel
Management of Kawasaki disease.
@en
Management of Kawasaki disease.
@nl
P2093
P2860
P921
P1476
Management of Kawasaki disease.
@en
P2093
D Eleftheriou
D Shingadia
P A Brogan
P2860
P356
10.1136/ARCHDISCHILD-2012-302841
P407
P5008
P577
2013-10-25T00:00:00Z
2014-01-01T00:00:00Z